Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PEBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAP2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GSTT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CABP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDFY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRR5-ARHGAP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WRNIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC2A1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATOH8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PADI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC8A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLK13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALS2CL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR61 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on